I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Dr. Andrée Bates is a pioneering force in pharmaceutical AI, known for transforming how life sciences companies harness data to drive growth, innovation, and patient outcomes. As Founder and CEO of Eularis, Dr. Bates has spent over two decades helping top-tier pharma and biotech firms solve complex commercial challenges using artificial intelligence. With a PhD in Neuroscience and Cognitive Science, and a career that began in medical writing and digital transformation, she’s long been at the forefront of healthcare innovation. Dr. Bates lectures in MBA programs on health innovation and AI, and contributing thought leadership, her work reflecting a rare blend of scientific rigor, commercial insight, and visionary thinking.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Paul McCormack, founder of in10tion Performance, whose journey from alcohol-fuelled routines to intentional, alcohol-free living has sparked a movement in personal transformation. After just 30 days without alcohol, Paul experienced such a profound shift in clarity, energy, and purpose that he never looked back. Now, he coaches others to unlock their full potential—without the booze. In the UK, over 20% of adults report drinking more than the recommended weekly limit of 14 units. Alcohol is linked to over 60 medical conditions, including high blood pressure, depression, and cancer. Yet, just one month alcohol-free can lead to a 40% drop in liver fat, improved sleep, and better concentration. Whether you're in pharma, coaching, or simply curious about the ripple effects of alcohol-free living, I hope this episode will offer insight, inspiration, and a fresh perspective on what it means to thrive.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Sverre Bengtsson is a trailblazer in clinical trial innovation and digital transformation. As Co Founder at Viedoc Technologies, he has helped shape one of the most widely adopted eClinical platforms in the world, streamlining trials across more than 80 countries and empowering thousands of research teams to work smarter and faster. He serves as an active Board Member of ACDM (Association for Clinical Data Management). reflecting a deep commitment to advancing data integrity and operational excellence across clinical research. With over three decades of experience, Sverre is also an active angel investor, backing more than 30 life science ventures across Europe.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Nuria Coll Bastus is an industry disruptor whose roots in academic research and oncogenomics have blossomed into a bold new vision for clinical trials. Born in Spain and now based in the UK, Nuria brings a cross-cultural lens to one of pharma’s most persistent challenges: patient recruitment. With over 12 years in drug development and a background in oncogenomics (Nuria holds an MBA that served as the launchpad for Clinical Net—a health-tech startup she founded to match patients with trials in under five minutes. Globally, 80% of clinical trials are delayed due to recruitment issues, costing billions annually. Nuria’s platform is changing that—automating access, centralizing data, and empowering both patients and practitioners.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Artem Adrianov. Mathematician. Strategist. Risk based quality mgt trailblazer. As co-founder and CEO of Cyntegrity, Dr. Artem Andrianov has spent over 25 years transforming clinical trials through data intelligence and risk-based methodologies. With a Ph.D. in Mathematical Modelling and an Executive MBA from Cass Business School, Artem blends scientific rigor with business acumen to make trials safer, smarter, and more efficient. Since launching Cyntegrity in 2013, he has led the development of platforms that optimize trial oversight, reduce monitoring costs, and elevate data quality. His work spans collaborations with big Pharma, and his expertise covers Spirometry, ECG, Oncology, ePROs, and centralized monitoring. A speaker and educator, Artem has presented at numerous global conferences, and co-authored the definitive guide to RBQM for clinical researchers. His company’s training arm, MyRBQM Academy, has educated over 1500 professionals from 400+ organizations, setting the standard for RBQM implementation worldwide. Whether modelling risk or mentoring the next generation of trial leaders, Artem is reshaping how the industry thinks about quality, reliability, and patient safety.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.” In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Anna Titkova is the International Operations Director at Pratia, one of Europe’s largest site networks, where she oversees operations across multiple countries with a focus on accessibility, innovation, and quality. Born and raised in Ukraine, Anna’s journey is marked not only by professional excellence but by personal courage. Leading a pan-European organization while her homeland faces the ongoing realities of war, she brings a unique perspective on what it means to build systems that endure—and to center compassion in every decision. Under Anna’s leadership, Pratia continues to expand its reach, integrating digital tools and local expertise to make clinical trials more inclusive and responsive to real-world needs.

“I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.” “In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?” Natalie Douglas is a transformative leader whose influence spans global pharma, biotech, and health tech. With over 25 years of board-level experience, Natalie has held CEO roles at Healthcare at Home and Health Outcomes Sciences, and led strategic growth at IDIS (now Clinigen). At Healthcare at Home, she oversaw one of Europe’s largest providers of complex clinical services outside the hospital setting, delivering care to over 150,000 patients annually and redefining how treatment reaches people where they live. Her accolades include: • 🏆 PharmaVoice Top 100 • 💼 Health Investor Power Top 50 • 🌟 Ernst & Young Entrepreneur of the Year Finalist • 🚀 Sunday Times Fast Track (Top Track, Buyout Track, Profit Track) Whether mentoring founders, entrepreneurs and new entrants to the industry or investing in scalable platforms, Natalie brings clarity to complexity—and a social conscience to strategy.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?  Dr. Keith Berelowitz is the founder and CEO of PRX engage a platform designed to revolutionize how we engage and retain patients in clinical trials with over 20 years of experience in pharma and biotech research. Keith blends proven methodologies and AI powered solutions to tackle one of the industry’s most pertinent challenges, keeping patients at the heart of research. Before launching pRxEngage, Keith founded Patient Rx Limited, a consultancy founded on tech enabled trial optimization. He also served as operations and commercials director at Richmond Pharmacology. Where his leadership contributed to significant revenue growth and global recognition, his strategic acumen extends beyond business. He currently chairs the Fulham Research Ethics Committee and has advised groups like the CRO Early Phase Working Group and the CCRA executive committee. What sets Keith apart isn’t just his resume, it’s his relentless focus on ethical, effective, and human centered research. His platform is built to support multi-stakeholder collaboration, to personalize engagement, and to improve retention across diverse populations. In an era where up to 30% of patients drop out of clinical trials, Keith’s work is more than innovation, it’s intervention.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Steve Sanghera is the CEO of Inventus, a UK-based innovator redefining how clinical trials are powered through secure, provisioned mobile devices. With a background steeped in digital transformation, Steve leads Inventus in delivering smartphones and tablets purpose-built for life sciences—ensuring compliance, data integrity, and patient-centric design. Under his leadership, Inventus has partnered with global tech leaders to simplify the complexities of device provisioning, making clinical research more agile, secure, and scalable.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Board certified internist, national speaker and host of the Lunch and Learn Podcast, which has surpassed 400 episodes and reached thousands of listeners worldwide. Today’s guest is Dr. Berry Pierre - with over 15 years of clinical experience, Dr. Pierre has treated patients across hospitals, rehab centers, and nursing homes, tackling everything from infectious diseases to chronic conditions like hypertension and coronary artery disease. But Dr. Pierre’s impact goes far beyond the clinic. He’s built a digital health ecosystem that includes blogs, vlogs, and educational series like Empower Yourself For Better Health, designed to demystify medicine and empower communities. His YouTube channel alone hosts over 2,000 videos, covering everything from vaccine hesitancy to the intersection of pop culture and public health. In this episode, we explore how Dr. Pierre uses storytelling to bridge the trust gap in healthcare—especially for underserved populations. We’ll discuss his advocacy for inclusive research, his insights on chronic disease management, and the power of transparency in clinical communication. Dr. Pierre doesn’t just inform—he inspires. Whether he’s breaking down complex medical topics or challenging systemic inequities, his voice is reshaping how we think about health, one conversation at a time.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Leigh Fell—a trailblazer in clinical research, a champion of corporate wellbeing, and the visionary founder of Caritas Science Solutions. Leigh’s journey from managing oncology trials to building a purpose-driven CRO is a masterclass in blending scientific rigor with human-centered leadership. With a degree in Physiology, Sport Science & Nutrition from the University of Glasgow, Leigh began her career running clinical trials for cancer therapies. In 2017, she launched Caritas with a bold mission: to create a company that not only advances medicine but also nurtures its people. Today, Caritas specializes in trials for brain disorders and oncology, partnering with pharma innovators to address areas of profound unmet need. Leigh’s leadership philosophy—what she calls corporate athleticism—has led to a 30% increase in employee retention and a culture where wellness and performance go hand in hand. That ethos earned her a place in The Sunday Times feature on “25 Women Succeeding in 2025”—a spotlight on visionary leaders shaping the future of business, science, and society with purpose and resilience. But Leigh’s impact goes beyond metrics. She’s redefining what it means to lead in life sciences: integrating yoga, marathon training, and mindfulness into the rhythm of business. Her belief? That building a company is like training for endurance—requiring discipline, resilience, and heart.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Anders Mortin is a seasoned eClinical professional with over two decades of experience in Clinical Development processes and systems. Known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions. As a co-founder of the Copenhagen-based pharma consulting firm, TriTiCon, established in 2015, he has been instrumental in shaping the company’s success. Anders holds a Master’s degree in Engineering Physics from Lund University in Sweden and has been a key player in the industry since the early 90’s. His extensive background in business, data, and project management has provided a solid foundation for TriTiCon’s diverse services.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Belma Alispahic, Co-Founder and Chief Scientific Officer of AnalysisMode. With a Master’s in Applied Biotechnology from Uppsala University and a track record of turning complexity into clarity, Belma is reshaping how we think about bioprocess development. At AnalysisMode, she leads the charge behind SimCell, an AI-powered platform designed to accelerate bioprocess efficiency, reduce time-to-market, and future-proof pharmaceutical workflows. Belma recently took the stage at the 9th Bioproduction Congress (BIOPC 2024) in France, where she shared her insights on “Future-Proofing with AI-Powered Bioprocess Development.” Her message was clear: AI isn’t optional—it’s essential for navigating the increasingly complex biopharma landscape. This isn’t just about algorithms—it’s about empowering scientists to make smarter decisions, faster. Belma’s work is a testament to what happens when deep scientific expertise meets bold technological vision.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents. By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%. Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits. Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors. Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? In this episode, we sit down with Philip Morisky, Chief Optimus at Adherence, to explore the missing metric in healthcare: medication adherence. Building on the legacy of the Morisky Medication Adherence Scale (MMAS), Philip shares how he’s transforming behavioral diagnostics into actionable insights—bridging the gap between validated measurement and real-world impact. From the evolution of MMAS-8R to the launch of ATLAS™, we unpack how fidelity, training, and data intelligence are reshaping global standards in patient care.

Welcome to the Pharma Prescribed podcast I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research. Today, we have the honour of hosting Yuriy Lebid, the dynamic CEO of Pharmaxi, a leading contract research organization based in Ukraine. Yuriy’s journey is nothing short of inspiring. Since the onset of the conflict on February 24, 2022, he has not only persevered but has continued to lead and innovate in the face of adversity. Pharmaxi LLC is a Contract Research Organization (CRO) with a keen focus on the regions of Ukraine and Poland. The organization offers a comprehensive range of services in the realm of clinical trials, with an emphasis on regulatory affairs, clinical monitoring, and data management. Under his supervision, we have developed ”OnlineCRF,” – an in-house Electronic Data Capture (EDC) system. This powerful tool enables efficient and accurate clinical data collection and trial monitoring. As the leader of Pharmaxi LLC, his personal objective is to establish a solid foundation for organic company growth while fostering a motivating work environment to attract talented and self-driven professionals. Join us as we delve into Yuriy’s remarkable story, exploring what drew him to the life sciences industry and how he has navigated the challenges to drive Pharmaxi’s success.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.” “In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Charbel Abdo. Born and raised in Lebanon, Charbel brings deep-rooted expertise and a global perspective to the future of pharmaceutical care. A fully qualified pharmacist, he built his clinical foundation in Lebanon and recently earned his MSc in Pharmaceutical Sciences—with distinction—at the University of Greenwich. Now based in the UK, Charbel is actively seeking his first opportunity in clinical research. With a passion for evidence-based practice and an eye for regulatory innovation, he’s ready to bring analytical precision and patient-first thinking to a forward-looking clinical trials team. He blends frontline experience with academic depth and is eager to step into the UK clinical research space, where he can apply scientific background and multicultural insight to make meaningful contributions to patient safety and trial excellence.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Matthew Mace. He is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts. Founder of Study Connect Inc., where he’s on a mission to streamline scientific innovation through faster trials and smarter collaboration. He’s not just building a platform—he’s shaping a movement. You might also know him as the host of the Study Success podcast, where he amplifies bold ideas and practical strategies driving real progress in our industry. And now, as a newly appointed Board Director at Precision Cardiovascular, he’s bringing his deep expertise in cardiac innovation to a company creating the next generation of monitoring tech. Previously, as Co-Founder and CSO at Acorai, Matthew led the largest hemodynamic study in heart failure history, secured FDA Breakthrough Device Designation, and raised over $10 million to bring a novel technology to market. With over 15 years across cardiology, AI, and medtech—plus a knack for turning vision into impact—Matthew brings unmatched perspective, purpose, and drive. He is passionate about new technologies and exploring the boundaries to continue the evolution of patient care. His aim is to further enhance the reach of lifesaving technology into the hands of healthcare professionals for the benefit of patients.

Welcome to the Pharma Prescribed podcast. I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research. Today’s guest is Charlotte Chadwick, CEO of Clinology - Making consultants more visible in Pharma and Biotech. The central ”why” lies in a commitment to impactful dialogues that highlight collaboration, innovation, and ethical practices.